
Cosmos Health Sets 1-for-20 Reverse Stock Split, Effective Nov. 12
The Nevada amendment takes effect at 4 p.m. local time on Nov. 12, and the company's authorized share counts stay unchanged.
Cosmos Health Inc. · Nasdaq · Wholesale-Drugs, Proprietaries & Druggists' Sundries

The Nevada amendment takes effect at 4 p.m. local time on Nov. 12, and the company's authorized share counts stay unchanged.
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| July 30, 2026 | Grigorios Siokas Chief Executive Officer, director, 10% owner | Bought | 349,825 | $0.20 | $70,000 |
| July 29, 2026 | Grigorios Siokas Chief Executive Officer, director, 10% owner | Bought | 766,284 | $0.18 | $140,000 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
AI summary, unreviewedCosmos Health Inc. Approves 1-for-20 Reverse Stock Split Effective November 12, 2026
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCosmos Health (COSM) Projects Q4 2026 U.S. Revenue of About $15 Million and Reaffirms Over $90 Million 2026 Revenue Outlook
Results of operations and financial condition · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits